LEADER 01675nam  2200445   450 
001 9910819309303321
005 20230803212412.0
010   $a92-4-069357-2
035   $a(CKB)3710000000326524
035   $a(EBL)1910125
035   $a(OCoLC)899158114
035   $a(MiAaPQ)EBC1910125
035   $a(Au-PeEL)EBL1910125
035   $a(EXLCZ)993710000000326524
100   $a20220517d2014      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aWHO drug information$hVol. 28 No. 3 2014. /$fby World Health Organization
210  1$aLondon, England :$cWorld Health Organization,$d[2014]
210  4$dİ2014
215   $a1 online resource (132 p.)
300   $aDescription based upon print version of record.
330   $aWHO Drug Information communicates pharmaceutical information that is either developed and issued by WHO or transmitted to WHO by research and regulatory agencies throughout the World. The journal also includes regular presentations of newly proposed and recommended International Nonproprietary Names (INN) for Pharmaceuticals Substances. This volume contains the recommended INN List No. 72
606   $aDrugs$xPhysiological effect
606   $aDrug abuse$xPrevention
606   $aPharmacology$vCongresses
615  0$aDrugs$xPhysiological effect.
615  0$aDrug abuse$xPrevention.
615  0$aPharmacology
676   $a616.1092358
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910819309303321
996   $aWHO drug information$92237802
997   $aUNINA